年龄和结肠直肠癌的结果:年轻和70岁以上的患者之间的比较分析
Oswaldo Moraes Filho1, Bruno Augusto Alves Martins1, André Araújo de Medeiros Silva1
1Coloproctology Service, University Hospital of Brasília, Setor de Grandes Áreas Norte 605, Asa Norte, Brasília 70840-901, DF, Brazil.
Current oncology (Toronto, Ont.)
|February 26, 2026
概括
长期年龄不是对结直肠癌患者的生存结果的重要预测因素. 对老年患者的治疗决策应侧重于个体生理学和疾病阶段,而不仅仅是年龄.
科学领域:
- 在瘤学瘤学.
- 老年医学 老年医学
- 外科手术的结果
背景情况:
- 结肠直肠癌主要影响到老年人,但基于年龄的治疗决定仍在争论中.
- 年代年龄通常用于外科手术的资格,但其对结果的影响尚不清楚.
研究的目的:
- 评估年龄是否是结直肠癌患者手术和瘤治疗结果的重要决定因素.
- 评估这个人群中年龄对生存的独立预测值.
主要方法:
- 在2014-2021年期间,对262名结直肠癌患者 (I-IV阶段) 进行了回顾性比较研究.
- 分析包括卡普兰-梅尔生存分析和考克斯比例危险回归.
- 患者被分为两组:70岁以下和70岁以上的患者.
主要成果:
- 老年患者的ASA分类,高血压患病率和ICU入院率较高,住院时间较长.
- 老年患者呈现较早阶段的疾病 (I+II阶段:64.2%对46.1%).
- 在调整了混杂因素后,年龄没有显著影响整体存活率 (p=0.5375) 或无病存活率 (p=0.1939).
结论:
- 仅仅年龄本身并不是接受切除的结直肠癌患者的生存结果的独立预测因素.
- 老年结肠直肠癌患者的治疗决策应考虑个体生理状态和疾病阶段.
- 个性化评估对于优化结直肠癌老年人护理至关重要.
更多相关视频
相关概念视频
Cancer Survival Analysis
797
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
797
Comparing the Survival Analysis of Two or More Groups
661
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
661
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
287
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
287
Pharmacodynamics in Geriatric Patients: Effects of Age
282
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
282
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
299
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
299
Longitudinal Research
13.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.5K


